Aedifica (AED) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Aedifica (AED) has a cash flow conversion efficiency ratio of 0.000x as of December 2022. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€75.00K ≈ $87.68K USD) by net assets (€3.29 Billion ≈ $3.85 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See AED defensive asset coverage days to measure how many days the company can operate on defensive assets alone.
Aedifica - Cash Flow Conversion Efficiency Trend (2005–2024)
This chart illustrates how Aedifica's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Aedifica Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Aedifica ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Cathay General Bancorp
NASDAQ:CATY
|
0.051x |
|
WPP PLC ADR
F:0WPA
|
-0.065x |
|
Veeco Instruments Inc
NASDAQ:VECO
|
0.009x |
|
Hafnia Ltd
OL:HAFNI
|
0.051x |
|
Kadant Inc
NYSE:KAI
|
0.069x |
|
Envista Holdings Corp
NYSE:NVST
|
0.025x |
|
Group 1 Automotive Inc
NYSE:GPI
|
0.046x |
|
Cleanaway Waste Management Ltd
AU:CWY
|
0.060x |
Annual Cash Flow Conversion Efficiency for Aedifica (2005–2024)
The table below shows the annual cash flow conversion efficiency of Aedifica from 2005 to 2024. For the full company profile with market capitalisation and key ratios, see AED stock market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | €3.65 Billion ≈ $4.27 Billion |
€248.50 Million ≈ $290.52 Million |
0.068x | +6.27% |
| 2023-12-31 | €3.58 Billion ≈ $4.19 Billion |
€229.53 Million ≈ $268.34 Million |
0.064x | -3.55% |
| 2022-12-31 | €3.29 Billion ≈ $3.85 Billion |
€218.60 Million ≈ $255.56 Million |
0.066x | -6.64% |
| 2021-12-31 | €2.79 Billion ≈ $3.26 Billion |
€198.27 Million ≈ $231.80 Million |
0.071x | +9.45% |
| 2020-12-31 | €2.17 Billion ≈ $2.54 Billion |
€141.32 Million ≈ $165.22 Million |
0.065x | +4.76% |
| 2018-12-31 | €1.43 Billion ≈ $1.67 Billion |
€88.76 Million ≈ $103.77 Million |
0.062x | -31.22% |
| 2017-12-31 | €941.65 Million ≈ $1.10 Billion |
€84.99 Million ≈ $99.36 Million |
0.090x | +15.91% |
| 2016-12-31 | €888.04 Million ≈ $1.04 Billion |
€69.15 Million ≈ $80.85 Million |
0.078x | -3.49% |
| 2015-12-31 | €620.75 Million ≈ $725.72 Million |
€50.09 Million ≈ $58.55 Million |
0.081x | +31.98% |
| 2014-12-31 | €598.27 Million ≈ $699.44 Million |
€36.57 Million ≈ $42.76 Million |
0.061x | -30.20% |
| 2013-12-31 | €397.07 Million ≈ $464.22 Million |
€34.77 Million ≈ $40.66 Million |
0.088x | +7.64% |
| 2012-12-31 | €382.16 Million ≈ $446.78 Million |
€31.09 Million ≈ $36.35 Million |
0.081x | -10.71% |
| 2011-12-31 | €267.58 Million ≈ $312.82 Million |
€24.38 Million ≈ $28.50 Million |
0.091x | +14.14% |
| 2010-12-31 | €273.97 Million ≈ $320.30 Million |
€21.87 Million ≈ $25.57 Million |
0.080x | -23.90% |
| 2009-12-31 | €180.76 Million ≈ $211.33 Million |
€18.96 Million ≈ $22.17 Million |
0.105x | +1.88% |
| 2008-12-31 | €172.72 Million ≈ $201.92 Million |
€17.78 Million ≈ $20.79 Million |
0.103x | +46.67% |
| 2007-12-31 | €193.91 Million ≈ $226.70 Million |
€13.61 Million ≈ $15.92 Million |
0.070x | +53.14% |
| 2006-12-31 | €177.39 Million ≈ $207.39 Million |
€8.13 Million ≈ $9.51 Million |
0.046x | +84.53% |
| 2005-12-31 | €57.00 Million ≈ $66.64 Million |
€1.42 Million ≈ $1.66 Million |
0.025x | -- |
About Aedifica
Aedifica is a Regulated Real Estate Company under Belgian law specialised in European healthcare real estate, particularly in elderly care. Aedifica has developed a portfolio of approx. 615 sites in Belgium, Germany, the Netherlands, the United Kingdom, Finland, Ireland and Spain, worth approx. 6.2 billion. Aedifica is listed on Euronext Brussels (2006) and Euronext Amsterdam (2019). Since 2020, … Read more